Barnes PJ - Search Results

1

Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-δ.

Mercado N, To Y, Ito K, Barnes PJ. Mercado N, et al. Among authors: barnes pj. J Pharmacol Exp Ther. 2011 May;337(2):465-70. doi: 10.1124/jpet.110.175950. Epub 2011 Feb 7. J Pharmacol Exp Ther. 2011. PMID: 21300705 Free PMC article.

2

Bradykinin receptor subtypes in rat lung: effect of interleukin-1 beta.

Tsukagoshi H, Haddad EB, Barnes PJ, Chung KF. Tsukagoshi H, et al. Among authors: barnes pj. J Pharmacol Exp Ther. 1995 Jun;273(3):1257-63. J Pharmacol Exp Ther. 1995. PMID: 7791098

3

Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.

Dent G, Giembycz MA, Evans PM, Rabe KF, Barnes PJ. Dent G, et al. Among authors: barnes pj. J Pharmacol Exp Ther. 1994 Dec;271(3):1167-74. J Pharmacol Exp Ther. 1994. PMID: 7996422

4

Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone.

Saunders MA, Mitchell JA, Seldon PM, Yacoub MH, Barnes PJ, Giembycz MA, Belvisi MG. Saunders MA, et al. Among authors: barnes pj. Br J Pharmacol. 1997 Feb;120(4):545-6. doi: 10.1038/sj.bjp.0700998. Br J Pharmacol. 1997. PMID: 9051287 Free PMC article.

5

Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type.

Belvisi MG, Saunders MA, Haddad el-B, Hirst SJ, Yacoub MH, Barnes PJ, Mitchell JA. Belvisi MG, et al. Among authors: barnes pj. Br J Pharmacol. 1997 Mar;120(5):910-6. doi: 10.1038/sj.bjp.0700963. Br J Pharmacol. 1997. PMID: 9138698 Free PMC article.

6

Mechanisms of prostaglandin E2 release by intact cells expressing cyclooxygenase-2: evidence for a 'two-component' model.

Saunders MA, Belvisi MG, Cirino G, Barnes PJ, Warner TD, Mitchell JA. Saunders MA, et al. Among authors: barnes pj. J Pharmacol Exp Ther. 1999 Mar;288(3):1101-6. J Pharmacol Exp Ther. 1999. PMID: 10027847

7

Strategies for novel COPD therapies.

Barnes PJ. Barnes PJ. Pulm Pharmacol Ther. 1999;12(2):67-71. doi: 10.1006/pupt.1999.0196. Pulm Pharmacol Ther. 1999. PMID: 10373383 Review. No abstract available.

8

SB 203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils.

Kankaanranta H, De Souza PM, Barnes PJ, Salmon M, Giembycz MA, Lindsay MA. Kankaanranta H, et al. Among authors: barnes pj. J Pharmacol Exp Ther. 1999 Aug;290(2):621-8. J Pharmacol Exp Ther. 1999. PMID: 10411570

9

Post-transcriptional regulation of bradykinin B1 and B2 receptor gene expression in human lung fibroblasts by tumor necrosis factor-alpha: modulation by dexamethasone.

Haddad EB, Fox AJ, Rousell J, Burgess G, McIntyre P, Barnes PJ, Chung KF. Haddad EB, et al. Among authors: barnes pj. Mol Pharmacol. 2000 Jun;57(6):1123-31. Mol Pharmacol. 2000. PMID: 10825382

10

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

Ito K, Barnes PJ, Adcock IM. Ito K, et al. Among authors: barnes pj. Mol Cell Biol. 2000 Sep;20(18):6891-903. doi: 10.1128/MCB.20.18.6891-6903.2000. Mol Cell Biol. 2000. PMID: 10958685 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,637 results

Search Page

Filters